In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
Hosted on MSN23h
GSK lowered to hold by Jefferies, valuation disconnect citedJefferies lowered GSK (NYSE:GSK) to hold, citing a valuation disconnect between fundamentals and price. Jefferies said it ...
GSK plc has an exclusive global license option to co-develop and commercialize XMT-2056. At the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting last week, Mersana presented new ...
DelveInsight's Glucose Syrup Market Insights report provides the current and forecast market analysis, individual leading ...
The "Diabetes Care Nutrition Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application" report has been added to ResearchAndMarkets.com's ...
DUBLIN, Nov. 12, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2024 ...
The glucose syrup market is largely driven by its rising demand within the food and beverage industry. Furthermore, the expanding uses and benefits of glucose syrup in the pharmaceutical sector ...
Several factors, including interest rate reductions, strong market performance and an incoming U.S. governmental ...
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback